Eurofins BioPharma Services Newsletter 33 - Ottobre 2022
Eurofins presenta la nuova edizione della newsletter BioPharma NEWS.
ARTICOLI CONTENUTI:
- Detection of mycobacterium species in qPCR as a consideration for cell banking testing in support of cell & gene therapy manufacturing
- Eurofins enhances vaccine development services
- Simplifying the audit process for drug manufacturers
- Eurofins BPT Italy expands efficacy testing capacity and capabilities against viruses
- Testing for rouge metals can help make pharmaceutical water and final drug products safer for patients
- Ready for MDR? Last chance to identify and close gaps in your documentation
Download PDF Pharma newsletter N°33
- Scarica le edizioni precedenti della nostra newsletter.
Cordiali saluti
Il comitato editoriale del gruppo Eurofins.